Researchers analyzed data on nearly 18,000 people from 8,541 Danish households between Dec. 20, 2021, and Jan. 18. The research has not been peer reviewed.
Four study findings:
1. For people exposed to BA.2 in their household, the likelihood of contracting COVID-19 within seven days was 39 percent, compared to 29 percent for those exposed to BA.1, the original omicron strain.
2. People had an increased risk of infection from the BA.2 strain regardless of vaccination status, “indicating an inherent increased transmissibility of the BA.2 subvariant,” researchers said in a Jan. 31 news release.
3. Relative to the original omicron strain, vaccinated individuals had a higher increase in susceptibility of infection from BA.2 compared to unvaccinated people, which suggests the subvariant can evade immune protection from vaccines better than BA.1, CNBC reported.
4. Vaccinated people infected with BA.2 transmitted the virus less than vaccinated people infected with the original strain.
“We conclude that omicron BA.2 is inherently substantially more transmissible than BA.1, and that it also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection, but do not increase its transmissibility from vaccinated individuals with breakthrough infections,” researchers said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.